FDA Orange Book · active-ingredient family
Etidronate disodium
Etidronate disodium is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:DIDRONEL · NDA 017831
2
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DIDRONELRLD×2 | APIL | NDA 017831 | — | Approved Prior to Jan 1, 1982 | |
| DIDRONEL | MGI PHARMA INC | NDA 019545 | — | Apr 20, 1987 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ETIDRONATE DISODIUM×2 | PHARMOBEDIENT | ANDA 075800 | — | Jan 24, 2003 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Etidronate disodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

